Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2004, p. 6676-6689, Vol. 24, No. 15
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.15.6676-6689.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110,1 Department of Pharmacology, New York University School of Medicine, New York, New York 100122
Received 20 October 2003/ Returned for modification 7 December 2003/ Accepted 28 March 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Humans and mice have at least eight SFKs, including Src, Fyn, and Yes. SFKs are composed of a tyrosine kinase domain, an SH2 domain, an SH3 domain, and a regulatory C-terminal region. They can be activated by receptor tyrosine kinases, cytokine receptors, G protein-coupled receptors, and integrins (reviewed in reference 70). SFK activation can cause cell cycle entry, cytoskeletal rearrangements, and alterations in cell adhesion (reviewed in reference 1). Mammalian tissue culture models have identified numerous downstream effectors of SFK functions; these include signaling molecules in the Ras/extracellular signal-regulated kinase (ERK), Jun kinase, Jak/STAT, and Rac/Rho pathways (70). SFK activities have not been well explored in vivo, however, in part due to functional redundancy among SFKs. For example, src/ mice show only subtle osteoclast defects while src/; fyn/; yes/ mouse embryos show early lethality and multiple developmental anomalies including neural tube defects and dramatically reduced size (37, 43, 63). Fibroblasts derived from src/; fyn/; yes/ mice show reduced proliferation, suggesting that some of the phenotypes of compound knockouts are caused by proliferative defects during development (37). However, the precise roles of Src, Fyn, and Yes in the cell cycle during development remain unknown.
SFKs are maintained in an inactive state through tyrosine phosphorylation of their C-terminal region by the negative regulator C-terminal Src kinase (Csk), which itself is closely related to SFKs (reviewed in reference 6). Deletion or mutation of the Csk target site leads to up-regulation of SFK activity (38, 52). Mammals have two Csk family members, Csk and Chk. Mice deficient for Csk show hyperactivation of SFKs and a striking embryonic phenotype also characterized by early lethality, neural tube defects, and reduced size (30, 49). Surprisingly, csk/ fibroblasts do not show increased proliferation, which conflicts with data indicating that increased SFK activity leads to cell cycle entry. This could reflect functional compensation by Chk, which also negatively regulates SFKs (26, 58). The redundancy between multiple SFKs and Csk as well as the early lethality of Csk and compound SFK knockouts has impeded detailed evaluation of SFK function in developing tissues.
Abnormal constitutive activation of SFKs has been implicated in oncogenesis (reviewed in reference 32). Numerous human tumors possess activated SFKs, but SFK mutations have been found in only a fraction of tumors. Some human colon cancers harbor mutations that abolish the ability of the C-terminal domain to inhibit Src kinase activity (31). The transforming v-Src oncogene shows deletion of the Csk target site (17). Since SFKs can be abnormally activated through disregulation of the C-terminal region, reduced Csk family kinase activity could promote oncogenesis. Yet, the role of Csk and/or Chk in tumors is controversial or unclear. Large deletions within the region of chromosome 15 that harbors Csk have been observed in colon cancers, the tumor types that commonly show elevated SFK activity (2, 7, 14, 19, 56), but no specific loss-of-function Csk mutations have been found in tumors to date. Reduced Csk expression and function is correlated with Src activation in primary hepatocellular tumors, primary colorectal tumors, and colon carcinoma cell lines (12, 45). However, others have reported elevated Csk in tumors with high SFK activity (73). In addition, csk/ primary mouse fibroblasts do not show a transformed phenotype (30, 49). Perhaps mutations in other loci, such as chk, are required to reveal a tumor suppressor function for Csk (26, 58). A detailed exploration of Csk function in vivo is required to understand its role in disease, but again, such studies have been impeded by the early lethality of csk/mice.
The imaginal disks of Drosophila melanogaster provide a powerful model system for the study of signal transduction. Imaginal discs share several properties with mammalian epithelial tissues: both are composed of epithelial cells that must maintain proportional growth, differentiation, and renewal to form functional tissues and organs. Cells within imaginal discs undergo proliferation and differentiation in response to molecular pathways that have been highly conserved across species and that function in oncogenesis. For example, studies of the eye imaginal disc have provided important evidence that the Ras and Jak/STAT signal transduction pathways are crucial for normal growth, proliferation, and differentiation (5, 25, 35, 44, 62). Recent genetic analyses of Drosophila tumor suppressor mutations have led to new insights about known human tumor suppressors and identification of new putative human tumor suppressors such as lats and salvador (34, 53, 67, 74).
The Drosophila genome contains two SFKs, Src42A and Src64B, that are functionally similar to their mammalian counterparts (20, 66). Src42A and Src64B loss-of-function mutations disrupt cytoskeletal regulation within developing oocytes and embryos (20, 68). Yet the full repertoire of SFK functions remains to be elucidated in Drosophila. Src42A and Src64B are regulated by a Csk-like activity in flies, but until now, the gene responsible for that activity was unknown (42). In this report, we present the cloning and characterization of the Drosophila Csk ortholog, dCsk. Loss of dCsk function led primarily to overgrowth phenotypes in developing tissues such as the eye; genetic data indicated that excess proliferation was due to up-regulation of SFKs. We provide evidence that this overgrowth required the JNK and STAT signal transduction pathways. Reducing STAT function prevented growth and normal differentiation of dCsk mutant tissue, instead provoking dCsk/ cells to undergo apoptosis. Our data provide in vivo evidence for a Src-dependent proapoptotic pathway triggered by reduced STAT function. They are consistent with results from Stewart et al. (64), published during submission of the manuscript of this report. Together, these results connect SFK signaling to the cell cycle and suggest an approach for restraining its proliferative potential.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Genomic and EST analysis. The sequence flanking the j1D8 and S030003 P-element insertions was generated and mapped by the Berkeley Drosophila Genome Project and Szeged Stock Center, respectively. The following CG17309 expressed sequence tags (ESTs) were obtained from the Berkeley Drosophila Genome Project and fully sequenced: LD36541, LP09923, GH10267, LD22810, and LD33364. Sequences were assembled, compared, and analyzed with BLAST, MultAlin, PROSCAN, and Genestream.
Rescue and reversion. To create the heat shock-inducible dCsk transgene hs-dCsk, the LD22810 cDNA was cloned into pPCaSpeR-hs, and stable insertions were created. dCskj1D8, dCskS030003, and dCskS017909 were extensively outcrossed to remove observed background mutations. w; hs-dCsk/+; dCsk/dCsk and w;+/+; dCsk/dCsk embryos were collected for 3 to 4 days in vials. Larvae were heat shocked at 37°C for 30 min every 10 to 16 h to induce dCsk expression. For reversion, S017909 and S030003 were excised by standard crosses; over 10 independent excisions were scored for reversion of lethality. j1D8 failed to excise.
Larval and pupal body size measurements. Embryos were collected for 4 h, and larvae were grown at similar densities. For mass measurements, larvae were cleaned and weighed in groups of 15 to 20 on a Mettler AE50 balance. A minimum of three groups was measured for each genotype at each time point. The average body mass was calculated by determining the average of the sum of the average body mass per group. Values for each time point were normalized to the average mass of wild-type control larvae. For pupal measurements, pupae were photographed and relative length measurements were taken from printed enlargements. Values were normalized to those of wild-type pupae.
Clonal analysis and flow cytometry. Flow cytometry was performed generally as described previously (51). Dissociated imaginal disc cells were run on a Cytomation MoFlo cytometer. Data were analyzed in Summit, version 3.1 (Cytomation). For analysis of loss-of-function clones, the genotypes were y w hs-FLP/+: FRT82B Ubi-GFPnlsS65T/FRT82B dCskj1D8 and y w hs-FLP/+; FRT82B Ubi-GFPnlsS65T/FRT82B dCskS030003. Clones were induced by heat shock at 48 and 72 h after embryo deposition (AED) and dissected at 120 h. Green fluorescent protein (GFP)-positive and -negative tissues were used to control for GFP detection and to set gates. Experiments were repeated at least three times.
Histology, immunohistochemistry, and scanning electron microscopy (SEM). In situ hybridization was performed as described previously (69) with a probe to the 5' end of both dCsk transcripts bounded by NcoI and BsgI sites. Negative controls lacked probe. Digoxigenin was detected with an alkaline phosphatase-conjugated antibody (Boehringer Mannheim).
For adult sections, heads were fixed in 1% glutaraldehyde-2% osmium tetroxide-phosphate-buffered saline (PBS), dehydrated, washed, and incubated for 4 h in 1:1 propylene oxide Durcupan ACM resin, overnight in 100% resin, and finally at 65°C to harden. Serial sections were stained with 0.5% methylene blue-0.1% toluidine blue. Digital photographs were taken on a Zeiss Axioplan.
For immunohistochemistry, tissue was fixed for 20 min in 4% paraformaldehyde with 1x PBS or 1x PEM and stains were performed in 1x PBS, 10% fetal bovine serum, and 0.3% Triton X-100. For antibodies, affinity-purified anti-Stat92E was used at 1:500 (15), anti-phospho-histone H3 (Upstate Biotechnology) was used at 1:200, anti-armadillo was used at 1:5, and 22C10 and active caspase 7 (New England Biolabs) were used at 1:4 and 1:50, respectively. Secondary antibodies were conjugated to Alexa Red or Green (Molecular Probes). For dCsk mitotic clones, we used ey-FLP/+; FRT82B Ubi-GFPnlsS65T/FRT82B dCsk. Digital photographs were taken on a Zeiss Axioplan. Confocal micrographs were taken by using the Zeiss LSM 510 system. To address cell autonomous growth, we did not rely on direct scoring of clonal patches within the eye disc in part because we were not able to reliably distinguish the boundaries of clones with single-cell resolution with the reagents available.
To estimate mitotic activity in larval discs, we examined printed enlargements of phosphohistone stains of EGUF discs. We controlled for tissue mass by counting phosphohistone-positive nuclei within a quadrant of fixed size such that we recorded the number of positive nuclei within identically sized fields of tissue for each genotype. Nuclei were counted in 3 quadrants per disc, and the average number of mitotic nuclei per quadrant was determined. For pupal discs, the total number of phosphohistone-positive cells were counted per disc.
For SEM, adult flies were fixed in 95% ethanol, rehydrated, treated with 1% osmium tetroxide, dried, and sputter coated. Ommatidia were counted on printed enlargements of SEMs. For dCskj1D8 EGUF clones, estimates of ommatidia were made by using SEMs of the entire eye plus separate SEMs to visualize folds.
| RESULTS |
|---|
|
|
|---|
|
During fly development, embryos hatch to progress through three larval stages followed by pupation and metamorphosis. dCsk mutants occasionally survived through later pupal development, allowing for characterization of dCsk/ larvae and pupae. The most striking phenotype of dCsk mutants was their increased body size relative to wild-type animals (Fig. 2A and B). Early third instar dCsk/ larvae weighed 30% more than age-matched wild-type larvae and eventually grew to weigh 84% more than wild-type larvae due to a prolonged larval stage in which they continued to feed and grow long after wild-type controls had formed a prepupa (Fig. 2A). dCsk/ pupae displayed a 21% increase in body length versus controls (Fig. 2B). Wandering dCsk mutant larvae showed enlargement of tissues such as the brain, ventral ganglion, and salivary glands and enlargement of the wing, leg, and eye imaginal discs (Fig. 2C and D) (data not shown). Delayed pupariation is frequently observed in Drosophila growth control mutants that show large larval body size and imaginal disc overgrowth; this delay may reflect defective coordination of larval growth and endocrine signals for metamorphosis (10, 11, 78).
|
To resolve the origin of the retinal defects, we utilized the EGUF system to generate whole-eye clones in which all adult eye tissue is homozygous for dCsk mutations in an otherwise heterozygous animal (65). This approach permitted us to isolate dCsk activity within the retina from effects of the prolonged larval stage; flies with eyes homozygous for dCsk mutations developed along a normal time course. dCsk/ EGUF clones were also enlarged in comparison to controls, with some dCskj1D8 clones so enlarged that the eyes became malformed to pack onto a normally sized head (Fig. 3A to D). Occasionally, dCsk/ EGUF clones resulted in antennal duplication and cuticle overgrowth, phenotypes that recapitulated defects seen in dCsk/ pharate adults (data not shown). These data indicate that dCsk regulates organ size within the developing eye.
|
Genotypically, dCsk/ EGUF eyes could be become enlarged either because dCsk/ cells grow faster than normal cells or because dCsk/ cells fail to exit the cell cycle properly and continue to proliferate when wild-type cells would not. To explore this issue, we took advantage of the tight control of mitoses during larval and pupal eye development. In the larval eye, the morphogenetic furrow is a region of cell cycle coordination in which no mitotic cells are normally present. Yet, mitotic cells were sometimes observed within the morphogenetic furrow in dCsk/ EGUF larval eye tissue (see also reference 64) (data not shown). The presence of mitotic cells in this region suggests that dCsk mutant cells fail to exit the cell cycle. The early pupal retina normally undergoes very little if any proliferation, restricted only to the precursor cells of the interommatidial bristles. Only an average of 2 mitotic cells were observed in wild-type tissue (2 ± 0.40, mean ± standard error [SE], n = 15). However, we observed an increase in mitotic cells in both dCskj1D8/S030003 whole mutant and dCskj1D8 EGUF pupal retinas (15 ± 4.2 mitotic cells, mean ± SE, n = 15) relative to wild-type controls, demonstrating that dCsk mutant cells do not normally exit the cell cycle (Fig. 3L to N). These proliferating cells were located within the interommatidial lattice, and some appeared to be bristle precursor cells (Fig. 3O and P). dCsk/ mutant pupal retinas contained excess interommatidial lattice cells (Fig. 3O and P), some of which are likely derived from increased lattice proliferation. Staining for apical cell profiles revealed that dCsk/ tissues had an average of 16 cells surrounding a single ommatidial cluster (16 ± 0.48, mean ± SE, n = 15) while control tissues showed an average of 12 cells surrounding a single cluster (12 ± 0.21, mean ± SE, n = 15).
To further explore the role of dCsk in cell proliferation, we utilized flow cytometry analysis in whole eyes and Flp-FRT-generated clones. First, our analysis demonstrated that dissociated cells from whole dCsk mutant eye-antennal and wing disks consistently exhibited a decrease in the G0-G1 population and an increase in the G2-M population compared to cells from age-matched control tissues (Fig. 4A and B). We found these differences in cell cycle profiles in mutant larvae over a range of ages, from 120 to 130 h AED. Similar results were observed with dCsk/ EGUF larval eyes (data not shown). To assess whether the defects observed with dCsk mutants are cell autonomous, we used the Flp-FRT system to generate mutant clones within the eye. To rigorously score the effects on individual cells (see also Materials and Methods), we dissociated the cells and used flow cytometry analysis to distinguish the dCsk homozygous clonal cells from their wild-type and heterozygous neighbors. dCsk mutant clones contained an increased G2-M population and a decreased G0-G1 population relative to surrounding control tissue (Fig. 4C), a cell cycle defect indicative of increased proliferation. These results are consistent with a similar analysis of the wing (64). Forward scatter measurements confirmed that dCsk homozygous clonal cells and their neighbors were the same average cell size even in different phases of the cell cycle (Fig. 4D to F). Together, these data argue that dCsk controls tissue growth cell autonomously by negatively regulating cellular proliferation without affecting cell size, although we cannot rule out subtle nonautonomous effects.
|
|
The JNK signaling pathway has also been identified as a mediator of Src signaling in both mammals and Drosophila (68). Consistent with this data, removing one copy of the JNK ortholog basket (bsk) also suppressed the dCsk phenotype. 60% of bsk1/+; dCskj1D8/S030003 flies formed viable adults that fully or partially eclosed (Fig. 5A). Similar to Src64BPI/+; dCskj1D8/S030003 survivors, bsk1/+; dCskj1D8/S030003 adults exhibited leg and wing defects and died shortly after eclosion (Fig. 5D). bsk1/+; dCskj1D8/S030003 larvae and pupae also showed suppression of the increased body size and prolonged larval phase observed in dCskj1D8/S030003 mutants (data not shown). FACS analysis indicated that bsk1/+; dCskj1D8/S030003 larval eye-antennal discs have an increased G0-G1 and decreased G2-M population relative to +/+; dCskj1D8/S030003 discs (Fig. 5B), demonstrating that mutations in bsk suppress the cell cycle defects caused by loss of dCsk.
dCsk negatively regulates Jak/Stat signaling. Another pathway linked to Src signaling in mammalian tissue culture models is the Jak/Stat signal transduction pathway. Src can directly phosphorylate and activate STAT3 in vitro, and STAT3 function and activation are required for Src transforming activity in multiple tissue culture cell lines (8, 13, 75). In the Drosophila eye, the Jak/Stat pathway controls proliferation and planar polarity. The Drosophila Jak/Stat pathway is composed of the ligand Unpaired (Upd), the receptor Domeless, the single Jak ortholog Hopscotch (Hop), and the single STAT ortholog Stat92E. Mutations that reduce the activity of hop or upd reduce the growth of the eye (5, 44), whereas gain-of-function mutations in Upd and Hop cause increased cellular proliferation within the eye and other tissues (4, 27). Overexpression of PIAS, a negative regulator of Stat92E, reduces growth of the eye (5). Loss-of-function mutations in hop and gain-of-function mutations in upd also disrupt planar polarity within the eye (76).
Recent work has demonstrated that Upd overexpression in the eye leads to a STAT-dependent overgrowth phenotype and ommatidial polarity defects very similar to those seen in our dCsk/ EGUF clones (Fig. 6B) (4, 15). In particular, Upd overexpression within the eye caused increased eye size by increasing the number of ommatidia and elevated cellular proliferation within undifferentiated cells anterior to the morphogenetic furrow, all without affecting ommatidial size or cell size (4); this phenotype is reminiscent of defects observed in dCsk/ EGUF clones. Removing one copy of Stat92E suppressed the Upd overexpression phenotype, demonstrating that the Upd phenotype was sensitive to alterations in Jak/Stat function (Fig. 6D). Removing one copy of dCsk enhanced eye overgrowth caused by Upd overexpression, demonstrating that dCsk negatively regulates the Jak/Stat pathway in this paradigm (Fig. 6B, C, E, and F).
|
dCsk phenotype requires Stat92E function. To further explore the role of Stat92E in dCsk function, we utilized the EGUF system to create eyes fully mutant for both dCsk and Stat92E; the presence of both loci on the same chromosomal arm simplified this approach. Eyes mutant for Stat92E alone were mostly normal, showing a slight reduction in size, some misaligned ommatidia and, infrequently, missing antennal structures (Fig. 7B). Genotypically, dCskj1D8; Stat92E06346 EGUF eyes were consistently and often significantly smaller than either dCskj1D8 or Stat92E06346 EGUF eyes alone, demonstrating a block in the overgrowth phenotype (Fig. 7A to E and G). In addition, dCskj1D8; Stat92E06346 adult eyes were frequently fragmented, with scars and/or patches of eye tissue separated by patches of cuticle (Fig. 7E), suggesting that mutant tissue underwent localized programmed cell death during development. dCskj1D8; Stat92E06346 EGUF eyes also showed loss of antennal structures and head cuticle malformations. The cuticle malformations were present on animals with small and scarred eyes, suggesting that these malformations are secondary to retinal defects. All of these observations were confirmed in dCskj1D8; Stat92Ej6C8 EGUF clones, which demonstrated an even higher penetrance of eye tissue loss (Fig. 7G).
|
To determine the developmental origin of the dCskj1D8; Stat92E/ EGUF phenotype, we examined eye-antennal imaginal discs. dCskj1D8; Stat92E06346 mutant larval eye-antennal discs frequently showed reduced sizes relative to controls, Stat92E/, or dCsk/ EGUF clones (Fig. 8A to D). dCskj1D8; Stat92E06346 EGUF clones also frequently showed a reduction or absence of developing antennal tissues. dCskj1D8; Stat92E06346 EGUF clones also showed reduced mitoses anterior to the morphogenetic furrow compared to control or dCskj1D8 clones (Fig. 8E). In addition, dCskj1D8; Stat92E06346 mutant larval eye tissue often exhibited patchy expression of neural markers within the developing eye field, and these regions also showed decreased proliferation relative to control or dCskj1D8 tissue (Fig. 8D). Regions with reduced neural development harbored cells with abnormal and pyknotic nuclei as visualized by 4',4'-diamidino-2-phenylindole (DAPI) staining (data not shown), suggesting that cells within the eye were undergoing apoptosis. Flow cytometry experiments indicated that dCskj1D8; Stat92E06346 larval eye tissue contained many apoptotic cells (data not shown). Consistent with these data, dCskj1D8; Stat92E06346 mutant larval eye tissue often exhibited increased programmed cell death and tissue loss within the developing eye field (Fig. 8F to H). This apoptosis primarily occurred in regions with reduced neural marker expression, indicating that defective neural differentiation may occur as a consequence of excessive apoptosis during development. Such extensive apoptosis is likely to disrupt the propagation of normal developmental processes in the eye field, accounting for much of the tissue loss and scarring observed in adult dCskj1D8; Stat92E/ EGUF clones. In summary, reducedStat92E activity inhibited SFK-mediated overgrowth in dCsk mutant tissue by reducing cell proliferation and promoting apoptotic cell death.
|
| DISCUSSION |
|---|
|
|
|---|
Partial reduction of Src64B, Src42A, or Btk29A activity suppressed the dCsk/ phenotype, providing functional data to support the view that the imaginal disc overgrowth, defective larval and pupal development, and lethality of dCsk/ mutants results from inappropriate activation of the Src-Btk signal transduction pathways. Mutations in Btk29A more strongly suppressed dCsk phenotypes than either Src42A or Src64B mutations, perhaps reflecting that (i) Src paralogs act redundantly to each other in Drosophila as in mammals (68) and (ii) Btk29A has previously been shown to act downstream of SFKs in flies and in mammals (24, 57, 59, 68). We provide in vivo evidence that loss of Csk function hyperactivates Btk to drive cell cycle entry in development, demonstrating that Tec-Btk family kinases are critical to SFK-mediated proliferation. Our data raise the possibility that partial reduction of Tec-Btk kinase activity could reduce proliferation in other cellular contexts in which overgrowth is driven by hyperactivated SFKs, such as in colon tumors.
Tissue culture models show that constitutively activated SFK signal transduction modulates the function of numerous downstream effector molecules and pathways. Using a loss-of-function approach to identify effectors that mediate the dCsk overgrowth phenotypes, we failed to implicate some of these pathways in dCsk function. For example, SFKs up-regulate the SOS-Ras-ERK pathway in multiple tissue culture studies and Drosophila overexpression models (for examples, see references 41, 60, and 66). However, although dRas1 signaling is active throughout retinal development, reduced dEGFR, Sos, and Jra (c-jun) gene dosage failed to affect the dCsk phenotype. dCsk mutations also failed to modify a hypermorphic allele of dEGFR (data not shown). Levels of doubly phosphorylated and activated ERK appeared unaltered in dCsk/ tissue (data not shown). Moreover, the dCsk phenotype failed to phenocopy defects caused by Ras pathway hyperactivation. For example, constitutively active dRas1 causes increased cell size and patterning defects in the developing imaginal discs (25, 35, 36, 54), defects that were not observed in dCsk mutant eye tissues. These data argue that not every signal transduction pathway implicated in SFK tissue culture models necessarily functions as predicted within a developing epithelial tissue.
Our studies emphasized the importance of two signaling pathways in dCsk and SFK function. Since certain defects in dCsk/ animals, such as a split notum, resembled those of hep (JNKK) mutants, we suspected that JNK pathway activity was involved in dCsk function (68). Phenotypic and FACS analysis established that reduced JNK (bsk) function suppressed the phenotypes and cell cycle defects caused by loss of dCsk. These results confirm studies indicating that JNK functions downstream of the Src-Btk pathway in Drosophila and mammalian tissue culture cells (50). Components of the JNK pathway are required for Src-dependent cellular transformation (22, 46, 72), but the exact role of JNK in these cells is unknown. Importantly, our data show that the JNK pathway mediates proliferative responses to Src signaling in vivo. Further work will be needed to precisely understand its role in proliferation.
Our genetic studies also highlighted the importance of the Jak/Stat signal transduction pathway. dCsk proved a negative regulator of Jak/Stat signaling; for example, dCsk mutant tissues show up-regulation of Stat92E protein, a hallmark of Jak/Stat activation in Drosophila. Stat92E, the sole Drosophila STAT ortholog, is most similar to mammalian STAT3. In mammalian cells, Src directly phosphorylates and activates STAT3 and STAT3 function and activation are required for Src transforming activity (8, 13, 75). Conversely, overexpression of Csk blocks STAT3 activation in v-Src transformed fibroblasts (55). Activating mutations in STAT3 can also promote oncogenesis in mice (9). However, the physiological significance of these interactions within developing epithelia remains unclear.
dCsk; Stat92E double mutant clones revealed that blockade of STAT function in dCsk mutants severely reduced Src-dependent overgrowth and promoted apoptosis of mutant tissue. dCsk/; Stat92E/ EGUF adult eyes are nearly identical to phenotypes caused by overexpression of Dacapo, the fly ortholog of the cdk inhibitor p21, and PTEN, a negative regulator of cell proliferation and growth (29, 61, 71). Importantly, removing Stat92E function in dCsk mutant tissue led to a synthetic small eye phenotype and did not simply rescue the dCsk/ proliferative phenotype. This outcome distinguishes Stat92E from mutations in Src64B, Btk29A, or bsk, which rescued dCsk-mediated defects toward a normal phenotype. The loss of tissue in dCsk/; Stat92E/ clones indicates that Src-Btk signaling provokes apoptosis in the absence of Stat92E function (Fig. 8I). Consistent with this interpretation, reduced Btk29A function rescued the dCsk/; Stat92E/ EGUF phenotype to a more normal phenotype, demonstrating that the reduced growth and increased apoptosis observed in the dCsk/; Stat92E/ tissues is indeed Src-Btk pathway dependent.
Our data suggest the existence of a Src-dependent proapoptotic pathway that is normally suppressed by STAT (Fig. 8I). One possible component of this pathway is JNK, given that JNK signaling is an important activator of apoptosis in both flies and mammals (16). Perhaps Src-dependent hyperactivation of Bsk (JNK) in dCsk/; Stat92E/ tissue contributes to cell death in the absence of proliferative and/or survival signals provided by Stat92E. However, a number of other candidate pathways may also mediate this response. The further characterization and identification of these pathways may have important implications for interceding in Src-mediated oncogenesis.
Together, these observations indicate that, in tissue that contains hyperactive Src or reduced Csk, blocking STAT function is sufficient to trigger apoptosis and decrease proliferation in the absence of any further mutations or interventions. Reduced STAT3 function can promote apoptosis within breast and prostate cancer cells that show elevated SFK activity, but the molecular pathways driving apoptosis in these cells are unknown (23, 47). These cells may require survival signals provided by STAT3 to counteract apoptosis due to chromosomal abnormalities or other defects. Alternatively, these cells may die because of proapoptotic signals provided by hyperactive SFKs in the absence of STAT3 function. Our data argue that the latter may be true, which suggests the intriguing possibility that therapeutic blockade of STAT function in tumors with activated Src may actively provoke Src-dependent apoptosis and growth arrest in tumor tissues.
| ACKNOWLEDGMENTS |
|---|
This research was supported by a grant from the National Cancer Institute (5R01CA084309-03) to R.L.C. and an NIH training grant to R.D.R.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Aligayer, H., D. D. Boyd, M. M. Heiss, E. K. Abdalla, S. A. Curley, and G. E. Gallick. 2002. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94:344-351.[CrossRef][Medline]
3. Baba, K., A. Takeshita, K. Majima, R. Ueda, S. Kondo, N. Juni, and D. Yamamoto. 1999. The Drosophila Bruton's tyrosine kinase (Btk) homolog is required for adult survival and male genital formation. Mol. Cell. Biol. 19:4405-4413.
4. Bach, E., S. Vincent, M. P. Zeidler, and N. Perrimon. 2003. A sensitized genetic screen to identify novel regulators and components of the Drosophila JAK-STAT pathway. Genetics 165:1149-1166.
5. Betz, A., N. Lampen, S. Martinek, M. W. Young, and J. E. Darnell, Jr. 2001. A Drosophila PIAS homologue negatively regulates stat92E. Proc. Natl. Acad. Sci. USA 98:9563-9568.
6. Bjorge, J. D., A. Jakymiw, and D. J. Fujita. 2000. Selected glimpses into the activation and function of Src kinase. Oncogene 19:5620-5635.[CrossRef][Medline]
7. Bolen, J. B., A. Veillette, A. M. Schwartz, V. DeSeau, and N. Rosen. 1987. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA 84:2251-2255.
8. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol 18:2553-2558.
9. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303.[CrossRef][Medline]
10. Bryant, P. J., and P. Levinson. 1985. Intrinsic growth control in the imaginal primordia of Drosophila, and the autonomous action of a lethal mutation causing overgrowth. Dev. Biol. 107:355-363.[CrossRef][Medline]
11. Buratovich, M. A., and P. J. Bryant. 1997. Enhancement of overgrowth by gene interactions in lethal(2)giant discs imaginal discs from Drosophila melanogaster. Genetics 147:657-670.[Abstract]
12. Cam, W. R., T. Masaki, Y. Shiratori, N. Kato, T. Ikenoue, M. Okamoto, K. Igarashi, T. Sano, and M. Omata. 2001. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma. Cancer 92:61-70.[CrossRef][Medline]
13. Cao, X., A. Tay, G. R. Guy, and Y. H. Tan. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595-1603.[Abstract]
14. Cartwright, C. A., M. P. Kamps, A. I. Meisler, J. M. Pipas, and W. Eckhart. 1989. pp60c-src activation in human colon carcinoma. J. Clin. Investig. 83:2025-2033.
15. Chen, H. W., X. Chen, S. W. Oh, M. J. Marinissen, J. S. Gutkind, and S. X. Hou. 2002. mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family. Genes Dev. 16:388-398.
16. Chen, Y. R., and T. H. Tan. 2000. The c-Jun N-terminal kinase pathway and apoptotic signaling. Int. J. Oncol. 16:651-662.[Medline]
17. Cooper, J. A., K. L. Gould, C. A. Cartwright, and T. Hunter. 1986. Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science 231:1431-1434.
18. Deak, P., M. M. Omar, R. D. Saunders, M. Pal, O. Komonyi, J. Szidonya, P. Maroy, Y. Zhang, M. Ashburner, P. Benos, C. Savakis, I. Siden-Kiamos, C. Louis, V. N. Bolshakov, F. C. Kafatos, E. Madueno, J. Modolell, and D. M. Glover. 1997. P-element insertion alleles of essential genes on the third chromosome of Drosophila melanogaster: correlation of physical and cytogenetic maps in chromosomal region 86E-87F. Genetics 147:1697-1722.[Abstract]
19. De Angelis, P. M., O. P. Clausen, A. Schjolberg, and T. Stokke. 1999. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br. J. Cancer 80:526-535.[CrossRef][Medline]
20. Dodson, G. S., D. J. Guarnieri, and M. A. Simon. 1998. Src64 is required for ovarian ring canal morphogenesis during Drosophila oogenesis. Development 125:2883-2892.[Abstract]
21. Dong, X., L. Tsuda, K. H. Zavitz, M. Lin, S. Li, R. W. Carthew, and S. L. Zipursky. 1999. ebi regulates epidermal growth factor receptor signaling pathways in Drosophila. Genes Dev. 13:954-965.
22. Fan, G., S. E. Merritt, M. Kortenjann, P. E. Shaw, and L. B. Holzman. 1996. Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapk but not ERK2. J. Biol. Chem. 271:24788-24793.
23. Garcia, R., T. L. Bowman, G. Niu, H. Yu, S. Minton, C. A. Muro-Cacho, C. E. Cox, R. Falcone, R. Fairclough, S. Parsons, A. Laudano, A. Gazit, A. Levitzki, A. Kraker, and R. Jove. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499-2513.[CrossRef][Medline]
24. Guarnieri, D. J., G. S. Dodson, and M. A. Simon. 1998. SRC64 regulates the localization of a Tec-family kinase required for Drosophila ring canal growth. Mol. Cell 1:831-840.[CrossRef][Medline]
25. Halfar, K., C. Rommel, H. Stocker, and E. Hafen. 2001. Ras controls growth, survival and differentiation in the Drosophila eye by different thresholds of MAP kinase activity. Development 128:1687-1696.[Abstract]
26. Hamaguchi, I., N. Yamaguchi, J. Suda, A. Iwama, A. Hirao, M. Hashiyama, S. Aizawa, and T. Suda. 1996. Analysis of CSK homologous kinase (CHK/HYL) in hematopoiesis by utilizing gene knockout mice. Biochem. Biophys. Res. Commun. 224:172-179.[CrossRef][Medline]
27. Harrison, D. A., R. Binari, T. S. Nahreini, M. Gilman, and N. Perrimon. 1995. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14:2857-2865.[Medline]
28. Hay, B. A., T. Wolff, and G. M. Rubin. 1994. Expression of baculovirus P35 prevents cell death in Drosophila. Development 120:2121-2129.[Abstract]
29. Huang, H., C. J. Potter, W. Tao, D. M. Li, W. Brogiolo, E. Hafen, H. Sun, and T. Xu. 1999. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126:5365-5372.[Abstract]
30. Imamoto, A., and P. Soriano. 1993. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73:1117-1124.[CrossRef][Medline]
31. Irby, R. B., W. Mao, D. Coppola, J. Kang, J. M. Loubeau, W. Trudeau, R. Karl, D. J. Fujita, R. Jove, and T. J. Yeatman. 1999. Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21:187-190.[CrossRef][Medline]
32. Irby, R. B., and T. J. Yeatman. 2000. Role of Src expression and activation in human cancer. Oncogene 19:5636-5642.[CrossRef][Medline]
33. Johansen, K. A., D. D. Iwaki, and J. A. Lengyel. 2003. Localized JAK/STAT signaling is required for oriented cell rearrangement in a tubular epithelium. Development 130:135-145.
34. Kango-Singh, M., R. Nolo, C. Tao, P. Verstreken, P. R. Hiesinger, H. J. Bellen, and G. Halder. 2002. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129:5719-5730.
35. Karim, F. D., H. C. Chang, M. Therrien, D. A. Wassarman, T. Laverty, and G. M. Rubin. 1996. A screen for genes that function downstream of Ras1 during Drosophila eye development. Genetics 143:315-329.[Abstract]
36. Karim, F. D., and G. M. Rubin. 1998. Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in Drosophila imaginal tissues. Development 125:1-9.[Abstract]
37. Klinghoffer, R. A., C. Sachsenmaier, J. A. Cooper, and P. Soriano. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459-2471.[CrossRef][Medline]
38. Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65-73.[CrossRef][Medline]
39. Kockel, L., J. Zietlinger, L. M. Staszewski, M. Mlodzik, and D. Bohmann. 1997. Jun in Drosophila development: redundant and nonredundant functions and regulation by two MAPK signal transduction pathways. Genes Dev. 11:1748-1758.
40. Kurada, P., and K. White. 1998. Ras promotes cell survival in Drosophila by downregulating hid expression. Cell 95:319-329.[CrossRef][Medline]
41. Kussick, S. J., K. Basler, and J. A. Cooper. 1993. Ras1-dependent signaling by ectopically-expressed Drosophila src gene product in the embryo and developing eye. Oncogene 8:2791-2803.[Medline]
42. Kussick, S. J., and J. A. Cooper. 1992. Overexpressed Drosophila src 64B is phosphorylated at its carboxy-terminal tyrosine, but is not catalytically repressed, in cultured Drosophila cells. Oncogene 7:2461-2470.[Medline]
43. Lowe, C., T. Yoneda, B. F. Boyce, H. Chen, G. R. Mundy, and P. Soriano. 1993. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA 90:4485-4489.
44. Luo, H., H. Asha, L. Kockel, T. Parke, M. Mlodzik, and C. R. Dearolf. 1999. The Drosophila Jak kinase hopscotch is required for multiple developmental processes in the eye. Dev. Biol. 213:432-441.[CrossRef][Medline]
45. Masaki, T., M. Okada, M. Tokuda, Y. Shiratori, O. Hatase, M. Shirai, M. Nishioka, and M. Omata. 1999. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma. Hepatology 29:379-384.[CrossRef][Medline]
46. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.[CrossRef][Medline]
47. Mora, L. B., R. Buettner, J. Seigne, J. Diaz, N. Ahmad, R. Garcia, T. Bowman, R. Falcone, R. Fairclough, A. Cantor, C. Muro-Cacho, S. Livingston, J. Karras, J. Pow-Sang, and R. Jove. 2002. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 62:6659-6666.
48. Morrison, D. K., M. S. Murakami, and V. Cleghon. 2000. Protein kinases and phosphatases in the Drosophila genome. J. Cell Biol. 150:F57-62.
49. Nada, S., T. Yagi, H. Takeda, T. Tokunaga, H. Nakagawa, Y. Ikawa, M. Okada, and S. Aizawa. 1993. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73:1125-1135.[CrossRef][Medline]
50. Nagao, M., Y. Kaziro, and H. Itoh. 1999. The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Galpha12. Oncogene 18:4425-4434.[CrossRef][Medline]
51. Neufeld, T. P., A. F. de la Cruz, L. A. Johnston, and B. A. Edgar. 1998. Coordination of growth and cell division in the Drosophila wing. Cell 93:1183-1193.[CrossRef][Medline]
52. Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49:75-82.[CrossRef][Medline]
53. Potter, C. J., G. S. Turenchalk, and T. Xu. 2000. Drosophila in cancer research. An expanding role. Trends Genet. 16:33-39.[CrossRef][Medline]
54. Prober, D. A., and B. A. Edgar. 2000. Ras1 promotes cellular growth in the Drosophila wing. Cell 100:435-446.[CrossRef][Medline]
55. Ram, P. T., C. M. Horvath, and R. Iyengar. 2000. Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein. Science 287:142-144.